
北美酶法 DNA 合成市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品类型(定制 DNA 合成和 DNA 文库合成)、应用(合成生物学、基因工程、治疗性抗体、疫苗设计和其他)、技术(SOLA、CRISPR、PCR 等)和最终用户(学术和研究机构、生物技术和制药公司、诊断实验室等)
No. of Pages: 137 | Report Code: BMIRE00028396 | Category: Life Sciences
No. of Pages: 137 | Report Code: BMIRE00028396 | Category: Life Sciences
唐氏综合症、自闭症谱系障碍、癌症、糖尿病、囊性纤维化和镰状细胞性贫血是一些常见的遗传性疾病。有些遗传性疾病在出生时就会出现症状,而另一些则随着时间的推移而出现症状。遗传疾病的全球负担似乎正在增加。根据美国医疗机构国家生物技术信息中心(NCBI)的数据,截至 2021 年 11 月,9.4% 的儿科患者被发现患有遗传性疾病,其中 44.7% 是危重新生儿。此外,美国有 1317 万患者患有独特的遗传性疾病。根据美国疾病控制与预防中心 (CDC) 2022 年报告,镰状细胞病影响约 10 万美国人,每 356 名非裔美国人新生儿中就有 1 人患有镰状细胞病。囊性纤维化是另一种全球常见遗传病,影响约 30,000 名美国公民,每年约有 1,000 例新病例接受治疗。酶促 DNA 合成是一种成熟的 DNA 合成技术,可用于合成生物学、基因工程和治疗性抗体研究。 DNA 合成与酶检测结合显示出更大的诊断可能性。这种方法提供了有关高危人群的重要信息,并帮助他们做出有关疾病诊断和药物治疗的重要决定。因此,随着全球遗传性疾病患病率的不断上升,人们越来越意识到早期检测这些遗传缺陷的必要性,这推动了北美酶法 DNA 合成市场的增长。
北美酶 DNA 合成市场分为美国、加拿大、和墨西哥。 2021 年,美国占据最大的市场份额。北美酶 DNA 合成市场的预计增长归因于领先市场参与者的存在及其产品开发以及遗传性疾病患病率上升等因素。 span>
北美酶 DNA 合成市场根据产品类型、应用、技术、最终用户、
根据产品类型,北美酶法 DNA 合成市场分为定制 DNA 合成和 DNA 文库合成。 DNA文库合成细分市场在2022年占据更大的市场份额。
基于应用,北美酶促DNA合成市场细分为合成生物学、基因工程、治疗性抗体、疫苗设计等。 2022年,合成生物学领域占据最大的市场份额。
根据技术,北美酶促DNA合成市场分为SOLA、CRISPR、PCR等。 PCR 细分市场在 2022 年占据最大的市场份额。
根据最终用户,北美酶 DNA 合成市场分为学术和商业领域。研究机构、生物技术和制药公司、诊断实验室等。生物技术和制药公司细分市场在 2022 年占据最大市场份额
根据国家/地区,北美酶 DNA 合成市场分为美国、加拿大和墨西哥。 2022 年,美国在北美酶法 DNA 合成市场份额中占据主导地位。
Ansa Biotechnologies, Inc.;卡梅纳生物; DNA 脚本;金斯瑞生物科技公司;分子组装;联生科技; Telesis生物公司;触摸灯;和 Twist Bioscience 是北美酶 DNA 合成市场上的几家领先公司。
Strategic insights for North America Enzymatic DNA Synthesis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 110.43 Million |
Market Size by 2028 | US$ 1,011.32 Million |
Global CAGR (2022 - 2028) | 44.6% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Enzymatic DNA Synthesis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Enzymatic DNA Synthesis Market is valued at US$ 110.43 Million in 2022, it is projected to reach US$ 1,011.32 Million by 2028.
As per our report North America Enzymatic DNA Synthesis Market, the market size is valued at US$ 110.43 Million in 2022, projecting it to reach US$ 1,011.32 Million by 2028. This translates to a CAGR of approximately 44.6% during the forecast period.
The North America Enzymatic DNA Synthesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Enzymatic DNA Synthesis Market report:
The North America Enzymatic DNA Synthesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Enzymatic DNA Synthesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Enzymatic DNA Synthesis Market value chain can benefit from the information contained in a comprehensive market report.